Tarsus Pharmaceuticals, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Tarsus Pharmaceuticals, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 6, 2025

Transcript

Slides

Quarterly report10-Q

Earnings release8-K

Q1 2025

May 1, 2025

Slides

Transcript

Quarterly report10-Q

Earnings release8-K

Corporate Presentation

May 1, 2025

Slides

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

Guggenheim SMID Cap Biotech Conference

Feb 6, 2025

Transcript

Investor Update

Jan 14, 2025

Slides

Press release

2024

Q4 2024

Feb 25, 2025

Slides

Transcript

Annual report10-K

Earnings release8-K

Q3 2024

Nov 13, 2024

Quarterly report10-Q

Earnings release8-K

Q2 2024

Aug 8, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 8, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Feb 27, 2024

Annual report10-K

Earnings release8-K

Q3 2023

Nov 9, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 10, 2023

Quarterly report10-Q

Earnings release8-K

FDA Announcement

Jul 25, 2023

Press release

Slides

Status Update

Jun 15, 2023

Slides

Q1 2023

May 9, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 17, 2023

Annual report10-K

2021

Q4 2021

Mar 14, 2022

Annual report10-K

2020

Q4 2020

Mar 31, 2021

Annual report10-K